Mouni Omar, Idrissi Anass, Bouziane Mohamed, Ahid Samir, Sair Khalid
Faculty of Medicine, Mohammed VI University of Health Sciences (UM6SS), Casablanca, Morocco.
Methodological Support Unit, Faculty of Pharmacy, Mohammed VI University of Health Science, Casablanca, Morocco.
Ann Med Surg (Lond). 2022 Oct;82:104471. doi: 10.1016/j.amsu.2022.104471. Epub 2022 Aug 27.
The COVID-19 pandemic had an undeniable impact on the health system worldwide, this lead to a delay in the diagnosis and treatment of digestive cancers.The purpose of our study was to assess this delay and its impact on patient care.
Our work is a retrospective study about 165 patients that were admitted for digestive cancers at Sheik Khalifa hospital, Casablanca morocco during a 3-year period, that we divided into three. We included all the digestive adenocarcinomas (esophagus excluded) whether they were operated on or not. We excluded all other types of cancers (GIST, serous tumors …). We assessed the time between the beginning of the symptoms and the beginning of the treatment and the number of patients that were diagnosed at the complication stage. We also assessed the staging of the tumor at the moment of diagnosis and the complete surgical resection rate.
Among the 165 patients admitted for digestive cancer, 54,9% were males with a sex ratio of 1,22 M/F. The average age of our patients was 62,8 years varying between 25 and 86 years old and with a standard deviation of 11,8 years. Digestive cancers were diagnosed in 79 patients during period 1, 43 patients during period2, and 43 during period 3. We found a statistically significant increase in the percentage of patients with advanced cancer by 21,7% (p = 0,045) from 2019 to 2020. The delay in diagnosis (p = 0,275), percentage of cancer discovered at the stage of complication(p = 0,728), and the reduction in complete surgical resection (p = 0,177) were not statistically significant.
Our results show an undeniable impact of the COVID-19 pandemic on the staging of digestive cancers but the impact on their care remains to be proven and needs a long-term survival follow-up.
新冠疫情对全球卫生系统产生了不可否认的影响，这导致了消化道癌症诊断和治疗的延迟。我们研究的目的是评估这种延迟及其对患者护理的影响。
我们的研究是一项回顾性研究，涉及165例在摩洛哥卡萨布兰卡的谢赫·哈利法医院因消化道癌症入院的患者，研究时间跨度为3年，我们将其分为三个时间段。我们纳入了所有消化道腺癌（不包括食管癌），无论是否接受手术治疗。我们排除了所有其他类型的癌症（胃肠道间质瘤、浆液性肿瘤等）。我们评估了症状出现到治疗开始的时间，以及在并发症阶段被诊断出的患者数量。我们还评估了诊断时肿瘤的分期以及完整手术切除率。
在165例因消化道癌症入院的患者中，54.9%为男性，男女比例为1.22。我们患者的平均年龄为62.8岁，年龄范围在25至86岁之间，标准差为11.8岁。在第1阶段有79例患者被诊断为消化道癌症，第2阶段有43例，第3阶段有43例。我们发现，从2019年到2020年，晚期癌症患者的百分比有统计学意义的增加，增加了21.7%（p = 0.045）。诊断延迟（p = 0.275）、在并发症阶段发现癌症的百分比（p = 0.728）以及完整手术切除率的降低（p = 0.177）均无统计学意义。
我们的结果显示，新冠疫情对消化道癌症的分期有不可否认的影响，但对其护理的影响仍有待证实，需要进行长期生存随访。
